TABLE 1.
Cohort characteristics of ESCC patient
| Characteristics | ITGAV expression levels | ||
|---|---|---|---|
| Low (n = 52) | High (n = 53) | p b | |
| Gender | |||
| Male | 40 (76.9%) | 37 (71.2%) | 0.41 |
| Female | 12 (23.1%) | 16 (28.8%) | |
| Age | |||
| ≤60 | 15 (28.8%) | 20 (38.5%) | 0.33 |
| >60 | 37 (71.2%) | 33 (61.5%) | |
| Pathology grade | |||
| I–II | 45 (86.5%) | 36 (69.2%) | 0.0297 |
| II–III | 6 (11.5%) | 9 (17.3%) | |
| III | 1 (1.9%) | 8 (15.4%) | |
| T classificationa | 0.0395 | ||
| T1 | 5 (9.6%) | 0 (0.0%) | |
| T2 | 5 (9.6%) | 7 (13.5%) | |
| T3 | 42 (80.8%) | 43 (82.7%) | |
| T4 | 0 (0.0%) | 3 (5.8%) | |
| N classification | 0.217 | ||
| N0 | 29 (55.8%) | 19 (36.5%) | |
| N1 | 14 (26.9%) | 20 (38.5%) | |
| N2 | 7 (13.5%) | 12 (23.1%) | |
| N3 | 2 (3.8%) | 2 (3.8%) | |
| Clinical stage | 0.139 | ||
| 1 | 5 (9.6%) | 2 (3.8%) | |
| 2 | 25 (48.1%) | 19 (36.5%) | |
| 3 | 22 (42.3%) | 32 (61.5%) | |
| 4 | 0 (0.0%) | 0 (0.0%) | |
a
Tumour TNM staging components, including Tumour (T), Node (N) and Metastasis (M), were defined according to the American Joint Committee on Cancer (AJCC) 7th edition.
b
Chi‐square text.